These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 23627786)

  • 1. Can MDMA play a role in the treatment of substance abuse?
    Jerome L; Schuster S; Yazar-Klosinski BB
    Curr Drug Abuse Rev; 2013 Mar; 6(1):54-62. PubMed ID: 23627786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress and promise for the MDMA drug development program.
    Feduccia AA; Holland J; Mithoefer MC
    Psychopharmacology (Berl); 2018 Feb; 235(2):561-571. PubMed ID: 29152674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a case for MDMA-assisted psychotherapy in the UK?
    Sessa B
    J Psychopharmacol; 2007 Mar; 21(2):220-4. PubMed ID: 17329304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDMA is certainly damaging after 25 years of empirical research: a reply and refutation of Doblin et al. (2014).
    Parrott AC
    Hum Psychopharmacol; 2014 Mar; 29(2):109-19. PubMed ID: 24590542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDMA to Treat PTSD in Adults.
    Latimer D; Stocker MD; Sayers K; Green J; Kaye AM; Abd-Elsayed A; Cornett EM; Kaye AD; Varrassi G; Viswanath O; Urits I
    Psychopharmacol Bull; 2021 Jun; 51(3):125-149. PubMed ID: 34421149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why MDMA therapy for alcohol use disorder? And why now?
    Sessa B
    Neuropharmacology; 2018 Nov; 142():83-88. PubMed ID: 29126911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MDMA or ecstasy: pharmacologic, toxicologic and clinical aspects].
    Prada C; Alvarez FJ
    Med Clin (Barc); 1996 Oct; 107(14):549-55. PubMed ID: 8999216
    [No Abstract]   [Full Text] [Related]  

  • 8. [3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].
    Molero-Chamizo A
    Rev Neurol; 2005 Jul 16-31; 41(2):108-14. PubMed ID: 16028190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ecstasy (MDMA) dependence.
    Jansen KL
    Drug Alcohol Depend; 1999 Jan; 53(2):121-4. PubMed ID: 10080038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychedelic Therapy: A Primer for Primary Care Clinicians-3,4-Methylenedioxy-methamphetamine (MDMA).
    Shinozuka K; Tabaac BJ; Arenas A; Beutler BD; Cherian K; Evans VD; Fasano C; Muir OS
    Am J Ther; 2024 Mar-Apr 01; 31(2):e141-e154. PubMed ID: 38518271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered states: the clinical effects of Ecstasy.
    Cole JC; Sumnall HR
    Pharmacol Ther; 2003 Apr; 98(1):35-58. PubMed ID: 12667887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
    Gouzoulis-Mayfrank E; Fischermann T; Rezk M; Thimm B; Hensen G; Daumann J
    Drug Alcohol Depend; 2005 Jun; 78(3):317-23. PubMed ID: 15893163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MDMA-assisted therapy for PTSD].
    Thorarinsdottir H; Gudmundsdottir B; Sigurdsson E
    Laeknabladid; 2024 May; 110(5):254-261. PubMed ID: 38713560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder.
    Bouso JC; Doblin R; Farré M; Alcázar MA; Gómez-Jarabo G
    J Psychoactive Drugs; 2008 Sep; 40(3):225-36. PubMed ID: 19004414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential dangers of using MDMA for psychotherapy.
    Parrott AC
    J Psychoactive Drugs; 2014; 46(1):37-43. PubMed ID: 24830184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder.
    Amoroso T
    J Psychoactive Drugs; 2015; 47(5):337-44. PubMed ID: 26579955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The entactogen 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) as a treatment aid in psychotherapy and its safety concerns.
    Baldo BA
    Arch Toxicol; 2024 Aug; 98(8):2409-2427. PubMed ID: 38743292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').
    McCann UD; Slate SO; Ricaurte GA
    Drug Saf; 1996 Aug; 15(2):107-15. PubMed ID: 8884162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ecstasy: a pharmacological review].
    Ferigolo M; Medeiros FB; Barros HM
    Rev Saude Publica; 1998 Oct; 32(5):487-95. PubMed ID: 10030068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.
    Ot'alora G M; Grigsby J; Poulter B; Van Derveer JW; Giron SG; Jerome L; Feduccia AA; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
    J Psychopharmacol; 2018 Dec; 32(12):1295-1307. PubMed ID: 30371148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.